Roderick McGeoch - Ramsay Health Non-Executive Independent Director
RMYHY Stock | USD 8.32 0.18 2.12% |
Director
Mr. Roderick Hamilton McGeoch AM LLB MAICD was NonExecutive Independent Director of Ramsay Health Care Limited since July 3 1997. He is a past Chairman of Corrs Chambers Westgarth an Australian law firm and was a solicitor for 40 years. He was Chief Executive of Sydneys bid for the 2000 Olympic Games and served on the Sydney Organising Committee for the Olympic Games until November 1998. Currently Mr. McGeoch is Chairman of Vantage Private Equity Group Limited and a Trustee of the Sydney Cricket Sports Ground Trust. Mr. McGeoch also holds various honorary positions and in 1990 was awarded membership of the Order of Australia for services to Law and the Community. Mr. McGeoch is CoChairman of the Australian New Zealand Leadership Forum and is also a director of Events NSW Pty Ltd. Mr. McGeoch has also served as a director of the following companies Sky City Entertainment Group Limited Telecom Corporation of New Zealand Limited Lipa Pharmaceuticals Limited BGP Holdings Plc. Malta and BGP Investment S.a.r.l Luxembourg . He is Chairman of the Company Remuneration and Nomination Committees. since 1997.
Tenure | 27 years |
Phone | 61 2 9220 1000 |
Web | https://www.ramsayhealth.com |
Ramsay Health Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0836 %, meaning that it generated $0.0836 on every $100 dollars invested by stockholders. Ramsay Health's management efficiency ratios could be used to measure how well Ramsay Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Daren Shaw | The Ensign Group | 61 | |
Tian Ji | Concord Medical Services | N/A | |
Kyle Lattner | Acadia Healthcare | 29 | |
Harold Paz | Select Medical Holdings | 62 | |
Wade Miquelon | Acadia Healthcare | 53 | |
Ernest Burgess | National HealthCare | 79 | |
EPerot Bissell | Acadia Healthcare | 58 | |
Lee Daniels | The Ensign Group | 61 | |
Leopold Swergold | Select Medical Holdings | 77 | |
William Frist | Select Medical Holdings | 69 | |
Weibo Yin | Concord Medical Services | 89 | |
James Ely | Select Medical Holdings | 63 | |
Leslye Katz | Encompass Health Corp | 66 | |
Paul Abernathy | National HealthCare | 82 | |
Ann Blouin | The Ensign Group | 65 | |
Vivian Liu | InnovAge Holding Corp | 54 | |
Parvinderjit Khanuja | Select Medical Holdings | 62 | |
Charles Elson | Encompass Health Corp | 60 | |
Katherine Davisson | Select Medical Holdings | 53 | |
Malene Davis | The Ensign Group | 55 | |
Ziad Mirza | InnovAge Holding Corp | 53 |
Management Performance
Return On Equity | 0.0836 | |||
Return On Asset | 0.0155 |
Ramsay Health Care Leadership Team
Elected by the shareholders, the Ramsay Health's board of directors comprises two types of representatives: Ramsay Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ramsay. The board's role is to monitor Ramsay Health's management team and ensure that shareholders' interests are well served. Ramsay Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ramsay Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Wearne, Global Exec | ||
LLB BECON, Group Sec | ||
Bruce Soden, Group Finance Director, Executive Director | ||
Kelly Hibbins, Group Relations | ||
Andrew Jones, Group Officer | ||
Craig McNally, Group COO | ||
Martyn Roberts, Group Officer | ||
John OGrady, Group General Counsel, Company Secretary | ||
Anthony Clark, Non-Executive Independent Director | ||
Michael Siddle, Non-Executive Chairman of the Board | ||
Doug Meagher, CFO Australia | ||
Peter Evans, Non-Executive Independent Deputy Chairman of the Board | ||
Patricia Akopiantz, Non-Executive Independent Director | ||
Colleen Harris, Group Officer | ||
Roderick McGeoch, Non-Executive Independent Director | ||
Christopher Rex, CEO, Managing Director, Executive Director | ||
Daniel Sims, CEO - Australian operations | ||
Margaret Seale, Non-Executive Independent Director | ||
AC DSc, Group Officer | ||
Ian Grier, Non-Executive Director | ||
Kerry Roxburgh, Non-Executive Independent Director | ||
Kah Hong, Group Care |
Ramsay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ramsay Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0836 | |||
Return On Asset | 0.0155 | |||
Profit Margin | 0.02 % | |||
Operating Margin | 0.03 % | |||
Current Valuation | 17.18 B | |||
Shares Outstanding | 915.53 M | |||
Price To Earning | 48.23 X | |||
Price To Book | 3.93 X | |||
Price To Sales | 0.72 X | |||
Revenue | 13.08 B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ramsay Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ramsay Health's short interest history, or implied volatility extrapolated from Ramsay Health options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ramsay Health Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Ramsay Health Care information on this page should be used as a complementary analysis to other Ramsay Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Ramsay Pink Sheet analysis
When running Ramsay Health's price analysis, check to measure Ramsay Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ramsay Health is operating at the current time. Most of Ramsay Health's value examination focuses on studying past and present price action to predict the probability of Ramsay Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ramsay Health's price. Additionally, you may evaluate how the addition of Ramsay Health to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |